Virologica Sinica

, Volume 23, Issue 6, pp 473–485

The biology of Kaposi’s sarcoma-associated herpesvirus and the infection of human immunodeficiency virus

Authors

  • Di Qin
    • Laboratory of Molecular Virology, Department of Microbiology and ImmunologyNanjing Medical University
    • Laboratory of Molecular Virology, Department of Microbiology and ImmunologyNanjing Medical University
Article

DOI: 10.1007/s12250-008-2996-x

Cite this article as:
Qin, D. & Lu, C. Virol. Sin. (2008) 23: 473. doi:10.1007/s12250-008-2996-x
  • 31 Views

Abstract

Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8), is discovered in 1994 from Kaposi’s sarcoma (KS) lesion of an acquired immunodeficiency syndrome (AIDS) patient. In addition to its association with KS, KSHV has also been implicated as the causative agent of two other AIDS-associated malignancies: primary effusion lymphoma (PEL) and multicentric Castleman’s disease (MCD). KSHV is a complex DNA virus that not only has the ability to promote cellular growth and survival for tumor development, but also can provoke deregulated angiogenesis, inflammation, and modulate the patient’s immune system in favor of tumor growth. As KSHV is a necessary but not sufficient etiological factor for KS, human immunodeficiency virus (HIV) is a very important cofactor. Here we review the basic information about the biology of KSHV, development of pathogenesis and interaction between KSHV and HIV.

Key words

Kaposi sarcoma-associated herpesvirus (KSHV)BiologyPathogenesisHIV

CLC number

Q786

Copyright information

© Wuhan Institute of Virology, CAS and Springer-Verlag GmbH 2008